1Kato H.Cardiovascular complications in Kawasaki disease:coronary artery lumen and long-term consequences[J].Progress in Pediatric Cardiology,2004,19:137-145.
2Sundel RP,Baker AL,Fulton DR,et al.Corticosteroids in the initial treatment of Kawasaki disease:report of a randomized trial[J].J Pediatr,2003,142:611-616.
3Jibiki T,Terai M,Kurosaki T,et al.Efficacy of intravenous immune globulin therapy combined with dexamethasone for the initial treatment of acute Kawasaki disease[J].Eur J Pediatr,2004,163:229-233.
4Shinohara M,Sone K,Tomomasa T,et al.Corticosteroids in the treatment of the acute phase of Kawasaki disease[J].J Pediatr,1999,135:465-469.
5Newburger JW,Takahashi M,Gerber MA,et.al.Diagnosis,treatment,and long-term management of Kawasaki disease:a statement for health professionals from the Committee on Rheumatic Fever,Endocarditis and Kawasaki Disease,Council on Cardiovascular Disease in the Young,American Heart-Association[J].Circulation,2004,110:2747-2771.
6Kijima Y,Kamiya T,Suzuki A,et al.A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease[J].Jpn Circ J,1982,46:1239-1242.
7Ogawa S,Ohkubo T,Fukazawa R.Estimation ofmyocardial hemodynamics before and after intervention in children with Kawasaki disease[J].J Am Coll Cardiol,2004,43:653-661.
8Tsuda E,Kamiya T,Ono Y,et al.Incidence of stenotic lesions predicted by acute phase changes in coronary arterial diameter during Kawasaki disease[J].Pediatr Cardiol,2005,26:73-79.
9Cheung YF,Yung TC,Tam SC.Novel and traditional cardiovascular risk factors in children after Kawasaki disease:imp licationsfor p remature atherosclerosis[J].J Am Coll Cardiol,2004,43:120-124.
10Kato H.Cardiovascular complication in Kawasaki disease coronary artery lumen and long-term consequence[J].Progress in pediatric cardiology,2004,19:137-145.